Skip to main content
Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
45.93
-5.38 (-10.49%)
At close: Dec 5, 2025, 4:00 PM EST
46.10
+0.17 (0.37%)
After-hours: Dec 5, 2025, 7:59 PM EST

Doximity Revenue

Doximity had revenue of $168.53M in the quarter ending September 30, 2025, with 23.16% growth. This brings the company's revenue in the last twelve months to $621.33M, up 20.21% year-over-year. In the fiscal year ending March 31, 2025, Doximity had annual revenue of $570.40M with 19.98% growth.

Revenue (ttm)
$621.33M
Revenue Growth
+20.21%
P/S Ratio
13.88
Revenue / Employee
$748,589
Employees
830
Market Cap
8.65B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025570.40M94.98M19.98%
Mar 31, 2024475.42M56.37M13.45%
Mar 31, 2023419.05M75.50M21.98%
Mar 31, 2022343.55M136.65M66.05%
Mar 31, 2021206.90M90.51M77.76%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

DOCS News

More News